Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma

NCT03616860 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

InSightec